进展期胃癌化疗疗效的影像学评估

doi:10.16139/j.1007-9610.2019.01.002

摘要/Abstract

中图分类号:

R735.2

张欢, 张阳. 进展期胃癌化疗疗效的影像学评估[J]. 外科理论与实践, 2019, 24(01): 6-9.

[1] Torre LA, Bray F, Siegel R, et al.Global cancer statistics, 2012: Global Cancer Statistics, 2012[J]. CA Cancer J Clin,2015,65(2):87-108.
[2] Eto K, Hiki N, Kumagai K, et al.Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications[J]. Gastric Cancer,2018,21(4):703-709.
[3] van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preo-perative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med,2012,366(22):2074-2084.
[4] Miller AB, Hoogstraten B, Staquet M, et al.Reporting results of cancer treatment[J]. Cancer,1981,47(1):207-214.
[5] Watanabe H, Okada M, Kaji Y, et al.New response eva-luation criteria in solid tumours: Revised RECIST guideline (version 1.1)[J]. Gan to Kagaku Ryoho,2009, 36(13):2495-2501.
[6] Choi H, Charnsangavej C, Faria SC, et al.Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria[J]. J Clin Oncol,2007,25(13):1753-1759.
[7] Kurokawa Y, Shibata T, Sasako M, et al.Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer(JCOG0507-A)[J]. Gastric Cancer,2014,17(3):514-521.
[8] Liu K, Li G, Fan C, et al.Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy[J]. Acta Radiol,2012,53(2):127-134.
[9] Park SR, Lee JS, Chan GK, et al.Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer[J]. Cancer,2008, 112(11):2368-2376.
[10] Gao X, Zhang Y, Yuan F, et al.Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy[J]. J Cancer Res Clin Oncol,2018,144(11):2207-2218.
[11] Luo Y, Chen J, Huang K, et al.Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?[J]. BMC Cancer,2017,17(1):154.
[12] Smith AD, Zhang X, Bryan J, et al.Vascular tumor burden as a new quantitative CT biomarker for predicting metastatic RCC response to antiangiogenic therapy[J]. Radiology,2016,281(2):484-498.
[13] Thian Y, Gutzeit A, Koh DM, et al.Revised Choi ima-ging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib[J]. Radiology,2014,273(2):452-461.
[14] Rombolà F, Caravetta A, Mollo F, et al.Sorafenib, risk of bleeding and spontaneous rupture of hepatocellular carcinoma. A clinical case[J]. Acta Medica (Hradec Kralove),2011,54(4):177-179.
[15] Di Fabio F, Pinto C, Rojas Llimpe FL, et al.The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab[J]. Gastric Cancer,2007, 10(4):221-227.
[16] Mesenas S, Vu C, Mcstay M, et al.A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy[J]. Dis Esophagus,2010,21(1):37-42.
[17] Yoshikawa T, Tanabe K, Nishikawa K, et al. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase Ⅱ study[J]. Ann Surg Oncol,2014,21 Suppl 3:S385-S389.
[18] 申屠伟慧, 黄品同, 鄢曹鑫, 等. 超声双重造影在进展期胃癌新辅助化疗疗效评价中的价值[J]. 中华超声影像学杂志,2016,25(3):212-217.
[19] 谭艳娟, 黄品同, 黄安茜, 等. 超声双重造影在进展期胃癌新辅助化疗后T分期及疗效评价中的价值[J]. 中华超声影像学杂志,2012,21(7):587-590.
[20] Kruk-Bachonko J, Krupski W, Czechowski M, et al.Perfusion CT-A novel quantitative and qualitative imaging biomarker in gastric cancer[J]. Eur J Radiol,2017,95:399-408.
[21] Lee SM, Kim SH, Lee JM, et al.Usefulness of CT vo-lumetry for primary gastric lesions in predicting patholo-gic response to neoadjuvant chemotherapy in advanced gastric cancer[J]. Abdom Imaging,2009,34(4):430-440.
[22] Chen XH, Ren K, Liang P, et al.Spectral computed tomography in advanced gastric cancer: Can iodine concentration non-invasively assess angiogenesis?[J]. World J Gastroenterol,2017,23(9):1666-1675.
[23] Tang L, Li ZY, Li ZW, et al.Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression[J]. Clin Radiol,2015,70(11):1198-1204.
[24] 张阳, 张欢, 闫静, 等. 双源双能量CT碘值在评估进展期胃腺癌新辅助化疗疗效中的价值[J]. 诊断学理论与实践,2018,17(2):191-196.
[25] Giganti F, Orsenigo E, Esposito A, et al.Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer[J]. Radiology,2015,276(2):444-452.
[26] Lee DH, Kim SH, Im SA, et al.Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study[J]. Eur Radiol,2016,26(8):2771-2778.
[27] Giganti F, De Cobelli F, Canevari C, et al.Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume correc-ted standardized uptake value with histological tumor regression grade[J]. J Magn Reson Imaging,2014,40(5):1147-1157.
[28] Schneider PM, Eshmuminov D, Rordorf T, et al.¹⁸FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study[J]. BMC Cancer,2018, 18(1):548.
[29] Park S, Ha S, Kwon HW, et al.Prospective evaluation of changes in tumor size and tumor metabolism in patients with advanced gastric cancer undergoing chemotherapy: association and clinical implication[J]. J Nucl Med,2017,58(6):899-904.
[30] Smyth E, Schöder H, Strong VE, et al.A prospective eva-luation of the utility of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer[J]. Cancer,2012,118(22):5481-5488.
[31] Chen R, Zhou X, Liu J, et al.Relationship between 18F-FDG PET-CT scans and HER2 expression in gastric cancer[J]. J Nucl Med,2016,57(7):1040-1044.
[32] Lee JW, Jo K, Cho A, et al.Relationship between 18F-FDG uptake on PET and recurrence patterns after curative surgical resection in patients with advanced gastric cancer[J]. J Nucl Med,2015,56(10):1494-1500.

进展期胃癌化疗疗效的影像学评估

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	周旻, 王利新, 符伟国. 主动脉夹层术后影像学随访进展及规范[J]. 外科理论与实践, 2022, 27(04): 284-287.
[2]	郭杨, 郭天安, 徐烨. 直肠癌新辅助化疗的研究进展[J]. 外科理论与实践, 2022, 27(04): 370-374.
[3]	罗东凤, 游建华, 李啸扬, 李军民, 张赟翔. 不耐受强化化疗的初治老年急性髓系白血病患者诱导治疗疗效及安全性[J]. 内科理论与实践, 2022, 17(03): 220-226.
[4]	马婧嶔, 杨敏捷, 颜志平. 精细TACE的治疗目标与栓塞终点[J]. 外科理论与实践, 2022, 27(02): 131-133.
[5]	张希昊, 章馨允, 曹曼卿, 张金梁, 王华琪, 张苏, 付周, 王鲁, 张倜. 肝细胞癌的抗血管生成免疫联合介入治疗：肝动脉灌注化疗与化疗栓塞疗效的比较[J]. 外科理论与实践, 2022, 27(02): 152-157.
[6]	吴莉莉, 许耀麟, 楼文晖. 放射治疗在胰腺癌治疗中的应用现状和展望[J]. 外科理论与实践, 2022, 27(01): 25-29.
[7]	姚伟武, 张欢. 线上教学对医学影像的影响及现状思考[J]. 诊断学理论与实践, 2022, 21(01): 99-101.
[8]	徐梁段惠川马晧钧李东周思政俞哲元韦敏袁捷. Ｃｒｏｕｚｏｎ综合征面中部截骨牵引术后气道改变的影像学分析 [J]. 组织工程与重建外科杂志, 2021, 17(3): 212-.
[9]	陈勇, 张欢. 线上自适应教程在医学影像学专业型硕士研究生教学实践中的应用[J]. 诊断学理论与实践, 2021, 20(06): 596-598.
[10]	谢安木, 栾梦葶, 王莹, 石万达. 肝豆状核变性的神经影像学表现[J]. 内科理论与实践, 2021, 16(05): 304-307.
[11]	孙应实, 卢巧媛, 管真, 张晓燕. 结肠直肠肿瘤的影像学诊断及评价[J]. 外科理论与实践, 2021, 26(04): 318-324.
[12]	李镛, 吴鹏亮, 方珍菲, 周进, 汤葳. 908例恶性孤立性肺小结节影像学征象的分析[J]. 内科理论与实践, 2021, 16(03): 193-196.
[13]	司安锋, 雷正清, 杨平华, 江涛, 王轩, 程张军. 巨块型肝内胆管癌术后经肝动脉化疗栓塞的有效性[J]. 外科理论与实践, 2021, 26(02): 138-143.
[14]	蔡晨, 龚伟. 胆囊癌辅助治疗的研究进展[J]. 外科理论与实践, 2021, 26(02): 167-170.
[15]	朱正纲. 预防与治疗胃癌腹膜转移的若干关键问题[J]. 外科理论与实践, 2021, 26(01): 1-6.